efgartigimod alfa
ItalyDrugs containing this active substance
-
It is used for the treatment of adults with generalized myasthenia gravis (gMG) and for adults with chronic inflammatory demyelinating polyneuropathy (CIDP), both autoimmune diseases that cause muscle weakness.
Form: solution for infusion, concentrate
Active substance Dosage efgartigimod alfa - ATC: L04AA58
Manufacturer: ARGENX BV